Measles: Clinical Trials

5 trials for Measles, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Terminated 1, Unknown 1
Phase 23Completed 1, Terminated 1, Unknown 1

Follow Measles: new trials by email Literature Review of Measles trials Research Report on Measles

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial
Measles Rubella Vaccine (MRV-SC), MRV-MNP, PLA-MNP - Measles, Rubella
Phase 1 / Phase 2CompletedMicron Biomedical, Inc2812021-05-192023-03-29
Phase I Trial of Measles Vectored Chikungungya Vaccine
Placebo, VRC-CHKVLP059-00-VP - Chikungunya Virus Infection
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1802017-05-302020-11-27
Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella
Double viral (MR) vaccine - Rubella, Measles
Phase 1CompletedThe Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)302015-09-012016-06-22
Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer
attenuated measles vaccine - Non-Small Cell Lung Cancer, Measles
Phase 1 / Phase 2UnknownSoroka University Medical Center152009-03-012009-01-23
Immune Responses to Two Dose Varivax +/- MMR-II
MMR-II, Pro-Quad, Varivax - Measles, Mumps
Phase 1 / Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)1052005-10-012010-08-27

Narrower conditions

Rubella (3)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Chickenpox (1)  ·  Chikungunya Fever (1)  ·  Mumps (1)

Broader conditions

Infections (5)  ·  Mononegavirales Infections (5)  ·  Morbillivirus Infections (5)  ·  Paramyxoviridae Infections (5)  ·  RNA Virus Infections (5)  ·  Virus Diseases (5)  ·  Togaviridae Infections (4)  ·  Rubivirus Infections (3)  ·  Alphavirus Infections (1)  ·  Arbovirus Infections (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  DNA Virus Infections (1)  ·  Herpesviridae Infections (1)  ·  Lung Diseases (1)

Interventions

Chickenpox Vaccine (1)  ·  Measles Vaccine (1)  ·  Rubella Vaccine (1)  ·  Vaccines (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Micron Biomedical, Inc (1)  ·  Soroka University Medical Center (1)  ·  The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (1)

Countries

United States (2)  ·  Brazil (1)  ·  Israel (1)  ·  The Gambia (1)

Top investigators

Ed Clarke, MD (1)  ·  Jose CerbinoNeto, PHD (1)

Results publications

PMID 36104719